EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
133 hedge funds and large institutions have $1.32B invested in Eagle Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 52 increasing their positions, 37 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
36% less call options, than puts
Call options by funds: $6.24M | Put options by funds: $9.75M
Holders
133
Holding in Top 10
6
Calls
$6.24M
Puts
$9.75M
Top Buyers
| 1 | +$40.4M | |
| 2 | +$16.8M | |
| 3 | +$16.7M | |
| 4 |
CM
Castleark Management
Chicago,
Illinois
|
+$11.8M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$8.87M |
Top Sellers
| 1 | -$19.1M | |
| 2 | -$17.7M | |
| 3 | -$7.51M | |
| 4 |
Two Sigma Investments
New York
|
-$6.44M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$5.48M |